Overview

Gender

male

Mr. Shuster formerly served as President of Invitrogen’s Genomics division, CEO of Kemia, CFO for Human Genome Sciences and Pharmacopeia through their IPOs, and board member and audit chair of Complete Genomics.

He is currently a board member with Response Biomedical, Mast Therapeutics and several privately held companies including Cleave Biosciences and MSN Healthcare, chairing the audit committees of these boards.

Mr. Shuster holds an MBA from the Stanford University Graduate School of Business and a BA in Economics from Swarthmore College.